Cargando…

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Hepatocellular carcinoma (HCC) is among the most common types of cancer. Liver transplantation (LT) and surgical resection (SR) are primary surgical treatment options for HCC. The aim of the study was to assess mortality within 2 years postdiagnosis among patients with HCC according to their treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golabi, Pegah, Fazel, Sofie, Otgonsuren, Munkhzul, Sayiner, Mehmet, Locklear, Cameron T., Younossi, Zobair M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340426/ https://www.ncbi.nlm.nih.gov/pubmed/28248853 http://dx.doi.org/10.1097/MD.0000000000005904

Ejemplares similares

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States
por: Golabi, Pegah, et al.
Publicado: (2016)

Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)
por: Golabi, Pegah, et al.
Publicado: (2016)

Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis
por: Sayiner, Mehmet, et al.
Publicado: (2017)

The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
por: Golabi, Pegah, et al.
Publicado: (2016)

Exercise as an intervention for patients with end-stage liver disease: Systematic review
por: Locklear, Cameron T., et al.
Publicado: (2018)

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
por: Sayiner, Mehmet, et al.
Publicado: (2018)

Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
por: Golabi, Pegah, et al.
Publicado: (2019)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
por: Golabi, Pegah, et al.
Publicado: (2020)

Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States
por: Shahab, Omer, et al.
Publicado: (2019)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care
por: Younossi, Zobair M., et al.
Publicado: (2016)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Nonalcoholic steatohepatitis: global impact and clinical consequences
por: Kabarra, Khaled, et al.
Publicado: (2021)

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
por: Golabi, Pegah, et al.
Publicado: (2018)

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality
por: Shahab, Omer, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States
por: Paik, James M., et al.
Publicado: (2020)

Sarcopenia, healthy living, and mortality in patients with chronic liver diseases
por: Van Dongen, Catherine, et al.
Publicado: (2022)

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
por: Golabi, Pegah, et al.
Publicado: (2020)

The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017
por: Paik, James M., et al.
Publicado: (2020)

The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017
por: Paik, James M., et al.
Publicado: (2021)

Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population
por: Arshad, Tamoore, et al.
Publicado: (2018)

Geographical disparities in hepatitis b virus related hepatocellular carcinoma mortality rates worldwide from 1990 to 2019
por: Zhang, Nancy S., et al.
Publicado: (2023)

Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease
por: Karrar, Azza, et al.
Publicado: (2019)

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
por: Golabi, Pegah, et al.
Publicado: (2019)

Survival prediction model for postoperative hepatocellular carcinoma patients
por: Ren, Zhihui, et al.
Publicado: (2017)

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review
por: Feng, Ningning, et al.
Publicado: (2022)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Younossi, Zobair M., et al.
Publicado: (2021)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Multiple ectopic hepatocellular carcinomas in the pancreas: A case report
por: Li, Zhigui, et al.
Publicado: (2017)

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
por: Zhao, Rongce, et al.
Publicado: (2017)

Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
por: Sahin, Tolga, et al.
Publicado: (2020)

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Radiofrequency Ablation Versus Surgical Resection for Small Unifocal Hepatocellular Carcinomas
por: Lei, J.Y., et al.
Publicado: (2014)

Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma
por: Schraiber, Luciana dos Santos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6h6ii23u3l64h9vb1kt3fl7cvt